University of Pennsylvania, Renal Division, Department of Medicine, Philadelphia, PA, USA.
Clin J Am Soc Nephrol. 2010 May;5(5):917-23. doi: 10.2215/CJN.08251109. Epub 2010 Mar 25.
The use of kidneys from donors at increased risk for viral infections (DIRVI) such as HIV could increase the number of transplants and decrease waiting times. This study aimed to identify the proportion of kidney transplant candidates that would accept a kidney from a DIRVI and the factors that influenced this decision.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Conjoint analysis was used to assess the conditions in which renal transplant candidates would accept a DIRVI kidney. Candidates completed 12 scenarios in which the waiting time for a kidney, the donor age as a surrogate for kidney quality, and the risk of contracting HIV were systematically varied.
Among 175 respondents, 42 (24.0%) rejected DIRVI kidneys under all conditions, 103 (58.9%) accepted DIRVI kidneys under some conditions, and 31 (17.7%) always accepted DIRVI kidneys. In multivariable logistic regression, patients were more likely to accept a DIRVI kidney when waiting time was longer, the donor was younger, and HIV risk was lower (P < 0.01 for each variable). Patients on dialysis (P < 0.01) and older patients (P = 0.04) more commonly accepted DIRVI kidneys, but self-rated sense of health was not associated with DIRVI kidney acceptance.
Most renal transplant candidates would accept a DIRVI kidney under some circumstances. These findings suggest that recipients can be allowed to make prospective choices regarding DIRVI kidney acceptance without hindering placement of these organs.
使用来自病毒感染风险增加的供体(如 HIV)的肾脏可以增加移植数量并减少等待时间。本研究旨在确定愿意接受 DIRVI 肾脏的肾移植候选者的比例,以及影响这一决定的因素。
设计、设置、参与者和测量:联合分析用于评估肾移植候选者接受 DIRVI 肾脏的条件。候选者完成了 12 个场景,其中肾脏的等待时间、供体年龄作为肾脏质量的替代指标以及感染 HIV 的风险被系统地改变。
在 175 名受访者中,42 名(24.0%)在所有情况下都拒绝 DIRVI 肾脏,103 名(58.9%)在某些情况下接受 DIRVI 肾脏,31 名(17.7%)始终接受 DIRVI 肾脏。在多变量逻辑回归中,当等待时间更长、供体更年轻且 HIV 风险更低时,患者更有可能接受 DIRVI 肾脏(每个变量 P < 0.01)。透析患者(P < 0.01)和年龄较大的患者(P = 0.04)更常接受 DIRVI 肾脏,但自我评估的健康状况与 DIRVI 肾脏接受无关。
大多数肾移植候选者在某些情况下会接受 DIRVI 肾脏。这些发现表明,在不阻碍这些器官放置的情况下,可以允许接受者对 DIRVI 肾脏的接受进行前瞻性选择。